Comprehensive Metabolic Panel Testing Market Size to Reach USD 22.97 Billion In 2028: Reports and Data

Growing awareness about early diagnosis and treatment of diseases, and advancements in point-of-care technology are significant key factors fueling market growth

New York, June 01, 2021 (GLOBE NEWSWIRE) -- Market size: USD 12.59 Billion in 2020, Market Growth: CAGR of 7.8%, Market Trends: Rising demand for immediate diagnosis and growing adoption of CMP testing 

The global comprehensive metabolic panel testing market size is expected to reach USD 22.97 billion in 2028 and register a CAGR of 7.8% according to the latest report by Reports and Data. Government initiatives to create awareness about various diseases and growing number of biopsy processes are some key factors driving global market revenue growth. 

A comprehensive metabolic panel is a group of 14 tests that help in evaluating body fluid balance, kidney and liver functioning, electrolytes, sugar levels, and blood protein levels. It is used to detect various chronic diseases. Demand for comprehensive metabolic panel testing systems is growing due to rising prevalence of chronic and target disorders, such as kidney disease, liver disorders, and diabetes, along with increasing geriatric population. Moreover, rising investments in research and development activities to develop novel and innovative products are further boosting market growth. In addition, increasing adoption of data-driven solutions for analyzing health conditions is expected to boost market growth in the coming years. 

However, increasing chances of false results due to unavailability of well-trained professionals for performing CMP testing and stringent regulatory framework are some key restraints affecting global market growth. 

Request free sample of this research report at:

Some key highlights in the report:

  • Among the disease segment, the diabetes segment is expected to account for fastest revenue growth during the forecast period. Rising prevalence of diabetes and growing requirement of early diagnosis are significant factors fueling segment revenue growth. 
  • Based on test types, the kidney segment is expected to maintain its dominating position throughout the forecast period. High revenue growth is attributable to rising prevalence of kidney disorders, diabetes, and hypertension and increasing need for kidney tests in geriatric population. 
  • Among end users, the laboratories segment is projected to account for robust revenue growth between 2021 and 2028. Increasing usage of diagnostic tests in laboratories and growing investments for advancements of laboratories are some key factors boosting growth of this segment in the comprehensive metabolic panel testing market. 
  • North America is expected to account for robust revenue growth throughout the forecast period due to access to advanced healthcare facilities, presence of leading market players, rising prevalence of chronic disorders, and growing adoption of CMP testing. 
  • Asia Pacific market is expected to account for fastest revenue growth between 2021 and 2028 owing to growing elderly population, and rising emphasis on early diagnosis of disease. 
  • The market in Middle East and Africa is expected to account for steady revenue growth throughout the forecast period owing to improving healthcare system in the region.

List of Top Key Players of Comprehensive Metabolic Panel Testing Market

  • Abbott Laboratories
  • Quest Diagnostics Incorporated
  • Sonic Healthcare
  • Laboratory Corporation of America Holdings
  • Laboratories
  • SYNLAB International GmbH
  • TCG Corp
  • Scion Lab Services, LLC

To identify the key trends in the industry, click on the link below:

For this study, Reports and Data has segmented the global comprehensive metabolic panel testing market based on Disease, Test Type, End User, And Region:

Disease Outlook (Revenue, USD Billion, 2018 - 2028)

  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Others

Test Type Outlook (Revenue, USD Billion, 2018 - 2028)

  • Electrolytes
  • Proteins
  • Kidney Tests
  • Glucose
  • Liver Functional Tests
  • Others

End User Outlook (Revenue, USD Billion, 2018 - 2028)

  • Laboratories
  • PoC (Point of Care)

Order Now:

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA

Browse similar research reports:

Specimen Validity Testing Market Size, Share & Analysis, By Product & Services (Products (Reagents, Calibrators & Controls, Assay Kits, Disposables), Services), By Type (Laboratory Testing, Rapid/POC Testing), By End-use (Workplaces, Drug Screening Laboratories, Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers, Others), and By Region, Forecast To 2028

Primary Care POC Diagnostics Market Size, Share & Analysis, By Product (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility Testing, Thyroid Testing, Hematology Testing, Lipid Testing, And Others), By End Use (Pharmacy And Retail Clinics, Physician Office, Urgent Care Clinics, And Others), And By Region Forecast To 2028

Predictive Genetic Testing & Consumer/Wellness Genomics Market Size, Share & Analysis, By Type (On-Premise, Cloud Based), By Application (Predictive Genetic Testing & Consumer Genomics, Wellness Genomics), By Setting Type (Clinic, Direct To Consumer, Hospital), And By Region Forecast To 2028

Ovarian Cancer Diagnostics Market Size, Share & Analysis, By Cancer Type (Epithelial Tumour, Germ Cell Tumour, Stromal Cell Tumour, Others), by Diagnosis Type (Biopsy, Blood Test, Imaging And Others), By End-Use (Hospital Laboratories, Cancer Diagnostic Centres, Research Institutes, Others), And By Region, Global Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release: